Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

K. I. Birkeland; P. D. Home; U. Wendisch; R. E. Ratner; T. Johansen; L. A. Endahl; K. Lyby; J. H. Jendle; A. P. Roberts; J. H. DeVries; L. F. Meneghini

doi:10.2337/dc10-1925

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

Diabetes Care ◽

10.2337/dc10-1925 ◽

2011 ◽

Vol 34 (3) ◽

pp. 661-665 ◽

Cited By ~ 121

Author(s):

K. I. Birkeland ◽

P. D. Home ◽

U. Wendisch ◽

R. E. Ratner ◽

T. Johansen ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Insulin Degludec ◽

Randomized Controlled ◽

Acting Insulin ◽

Long Acting ◽

New Generation

Download Full-text

A Randomized, Controlled Trial Comparing Twice-a-Day Insulin Glargine Mixed With Rapid-Acting Insulin Analogs Versus Standard Neutral Protamine Hagedorn (NPH) Therapy in Newly Diagnosed Type 1 Diabetes

PEDIATRICS ◽

10.1542/peds.2007-1679 ◽

2008 ◽

Vol 121 (3) ◽

pp. e466-e472 ◽

Cited By ~ 23

Author(s):

K. Hassan ◽

L. M. Rodriguez ◽

S. E. Johnson ◽

S. Tadlock ◽

R. A. Heptulla

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Newly Diagnosed ◽

Insulin Analogs ◽

Randomized Controlled ◽

Acting Insulin ◽

Neutral Protamine Hagedorn

Download Full-text

Acylated-based long-acting insulin analogues: Is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes

Diabetes & Metabolism ◽

10.1016/j.diabet.2014.10.001 ◽

2014 ◽

Vol 40 (6) ◽

pp. 483-484 ◽

Cited By ~ 1

Author(s):

L. Monnier ◽

C. Colette ◽

D. Owens

Keyword(s):

Type 1 Diabetes ◽

Insulin Glargine ◽

Insulin Analogues ◽

Insulin Degludec ◽

Insulin Antibody ◽

Daily Insulin ◽

Acting Insulin ◽

Long Acting

Download Full-text

Insulin degludec in Japanese patients with type 1 diabetes mellitus: A randomized controlled trial

Journal of Diabetes Investigation ◽

10.1111/j.2040-1124.2012.00240.x ◽

2012 ◽

Vol 4 (1) ◽

pp. 62-68 ◽

Cited By ~ 13

Author(s):

Yasuhiko Iwamoto ◽

Per Clauson ◽

Tomoyuki Nishida ◽

Kohei Kaku

Keyword(s):

Diabetes Mellitus ◽

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Type 1 Diabetes Mellitus ◽

Controlled Trial ◽

Japanese Patients ◽

Insulin Degludec ◽

Randomized Controlled

Download Full-text

Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring

Diabetes Obesity and Metabolism ◽

10.1111/dom.13751 ◽

2019 ◽

Vol 21 (8) ◽

pp. 1906-1913 ◽

Cited By ~ 3

Author(s):

Jeremy Pettus ◽

Jasvinder Gill ◽

Sachin Paranjape ◽

John Stewart ◽

Shilpy Malla ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Continuous Glucose Monitoring ◽

Controlled Trial ◽

Glucose Monitoring ◽

Adult Patients ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial

Diabetes Care ◽

10.2337/dc19-1926 ◽

2020 ◽

Vol 43 (7) ◽

pp. 1512-1519 ◽

Cited By ~ 3

Author(s):

Thomas Danne ◽

William V. Tamborlane ◽

Oleg A. Malievsky ◽

Denise R. Franco ◽

Tomoyuki Kawamura ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Children And Adolescents ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12619 ◽

2016 ◽

Vol 18 (4) ◽

pp. 375-383 ◽

Cited By ~ 52

Author(s):

M. Matsuhisa ◽

M. Koyama ◽

X. Cheng ◽

Y. Takahashi ◽

M. C. Riddle ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Glucose Control ◽

Controlled Trial ◽

Randomized Controlled ◽

Japanese Adults ◽

Mealtime Insulin

Download Full-text

Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes: a phase III , randomized, controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14463 ◽

2021 ◽

Author(s):

Xiang Yan ◽

Shan Jiang ◽

Ying Lou ◽

Zhiguang Zhou

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Phase Iii ◽

Chinese Patients ◽

Comparable Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

Abstract #984349: Transition from Insulin pump to Multiple Daily Injections using Insulin Degludec in Adults with Type 1 Diabetes: A Randomized controlled trial

Endocrine Practice ◽

10.1016/j.eprac.2021.04.528 ◽

2021 ◽

Vol 27 (6) ◽

pp. S27-S28

Author(s):

Viral Shah ◽

Halis K. Akturk ◽

Hal Joseph ◽

Nicole Schneider ◽

janet K. Snell-Bergeon

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Pump ◽

Controlled Trial ◽

Insulin Degludec ◽

Randomized Controlled ◽

Multiple Daily Injections

Download Full-text

Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine ( L antus®) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study

Diabetes Obesity and Metabolism ◽

10.1111/dom.12496 ◽

2015 ◽

Vol 17 (8) ◽

pp. 726-733 ◽

Cited By ~ 44

Author(s):

T. C. Blevins ◽

D. Dahl ◽

J. Rosenstock ◽

L. L. Ilag ◽

W. J. Huster ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Type 1 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled

Download Full-text

A New-Generation Ultra-Long-Acting Basal Insulin With a Bolus Boost Compared With Insulin Glargine in Insulin-Naive People With Type 2 Diabetes: A randomized, controlled trial

Diabetes Care ◽

10.2337/dc10-1905 ◽

2011 ◽

Vol 34 (3) ◽

pp. 669-674 ◽

Cited By ~ 66

Author(s):

T. Heise ◽

C. J. Tack ◽

R. Cuddihy ◽

J. Davidson ◽

D. Gouet ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Glargine ◽

Basal Insulin ◽

Controlled Trial ◽

Randomized Controlled ◽

Long Acting ◽

New Generation

Download Full-text